Leo Cancer Care secures $65M series D to advance upright radiotherapy system

Medical technology company Leo Cancer Care closed a $65 million series D financing round to scale its radiotherapy solution that uses groundbreaking upright treatment technology. | Medical technology company Leo Cancer Care closed a $65 million series D financing round to scale its radiotherapy solution that uses groundbreaking upright treatment technology.